Science & Research

List of OWH Research Program Awards by Funding Year

The FDA Office of Women’s Health (OWH) awards research grants for 1-2 year studies to address regulatory research questions related to women's health issues and the impact of sex differences on product safety and efficacy.

Intramural, Extramural and Special Funding Research Initiatives by Funding Year


Bayesian demographic subgroup analyses for pregnant women - Judy X. Li, PhD/CBER

Treating the pregnant patient: pharmacokinetic and mechanistic studies of antiviral IGIV preparations at different stages of gestation in an animal model of pregnancy - Evi Struble, PhD/CBER

Effect of procoagulant impurity on coagulation in plasma from pregnant women - Mikhail Ovanesov PhD/CBER

Modulatory effects of progesterone on maternal immunity and their implications in pregnancy-associated susceptibility to avian influenza infections- Hang Xie, PhD/ CBER

Addressing the unmet medical needs for cardioprotection in women receiving chemotherapy - Ashutosh Rao, PhD/CDER (Supplementary funds)

Sex-specific modeling and analysis of ACL injury susceptibility- James Coburn/CDRH

Individual patient-data meta-analysis and postmarket analysis as a method for improving data quality in demographic subgroups - Daniel Canos, PhD/CDRH (Support for implementation of FDASIA Section 907 Action Plan)

Preclinical test methods for percutaneously implanted heart valves - effect of non-circular valve configuration after implantation on valve leaflet dynamics - Terry Woods, PhD/CDRH

Sex-specific outcomes with cardiac resynchronization therapy - Daniel Canos, PhD/CDRH  (Support for implementation of FDASIA Section 907 Action Plan)

The effects of gender differences in adverse events for integrated fixation spinal implants - Srinidhi Nagaraja, PhD/CDRH

Identifying and characterizing key mechanical characteristics of surgical meshes used for pelvic organ prolapse repair and treatment of stress urinary incontinence in women - Terry Woods, PhD/CDRH (Supplementary Funds)

Bacterial colonization and biofilm formation in dermal fillers implants: An in vivo model to confirm in vitro findings and pathogenesis leading to adverse events - Kenneth Phillips, PhD, CDRH

Gender differences in neuronal reward circuit activation by nicotine and tobacco smoke using magnetic resonance spectroscopy - Serguei Liachenko, PhD/NCTR

A pilot study for evaluating genetic influences on sex differences of drug-induced – proarrhythmia - Li Pang, MD/ NCTR

Oncomutation profile of triple negative breast cancer: Additional studies in African American women - Meagan Myers, PhD/NCTR

Population-based computational framework for assessing xenobiotic disposition and interaction effects in pregnant women - Annie Lumen, PhD/NCTR (Supplementary Funds)


Bayesian assessment of safety profiles for pregnant women-From animal study to human clinical trial - Judy X. Li, PhD/CBER

Evaluation of pharmacokinetics of thrombogenic impurity following different routes of immune globulin administration during pregnancy - Mikhail Ovanesov, Ph.D./CBER

Novel therapeutic approaches to prevent drug-induced torsade de pointes - Norman Stockbridge, MD, PhD/CDER

Develop animal and cellular models to investigate the mechanisms of cardiotoxicity induced by trastuzumab, trastuzumab/pertuzumab, and ado-trastuzumab emtansine to support post-marketing surveillance of these antibody-based HER2-targeted therapies, and characterize novel serum biomarker of cardiotoxicity induced by trastuzumab, trastuzumab/pertuzumab, and ado-trastuzumab emtansine - Wen Jin Wu, MD, PhD/ CDER

Disease systems analysis: towards a generic framework for characterizing disease progression and treatment effects in osteoporosis - Li Li Ph.D./CDER

Phantom-based evaluation of photoacoustic imaging systems for breast tumor vasculature quantification - Brian Garra, M.D/ CDRH

Calcium and material characterization in women using dual-energy computed tomography - Nicholas Petrick/CDRH

Follicle-stimulating hormone (FSH) may exacerbate local and systemic effects of wear particles released from metal-on-metal hip implants: Implications for women - Steven C. Wood Ph.D./CDRH

Simulation of realistic masses on mammograms and digital breast tomosynthesis images for system assessment and CAD development/testing - Berkman Sahiner PhD/CDRH

Blood pressure threshold for cardiovascular disease risk: an assessment of sex-based criterion - Ching-Wei Chang/NCTR

Evaluation of methods used to measure growth of staphylococcus aureus and the production of toxic shock syndrome toxin-1 as influenced by menstrual tampons - Mark E. Hart, Ph.D./ NCTR

Sex differences in drug-induced QT prolongation and torsade de pointes: establishing an in vitro model for high-throughput screening and risk assessment of torsadogenic drugs - Li Pang, MD/ NCTR

Detection of synthetic drugs as adulterants in natural and herbal slimming products by UPLC-mass spectrometry - Phyllis Wilson/ORA

Return to Top


Indira Hewlett, PhD, CBER
Evaluation of HSV-2 co-infection and hormonal contraceptive use on HIV acquisition and pathogenesis using patient-derived clinical specimens

Evi Struble, PhD, CBER
Assessing Passive Prophylaxis of Infection at Different Stages during Gestation in a Pregnant Animal Model

Daniela Verthelyi, MD, PhD, CDER
Use of innate immune response modulators in women: The perfect storm to trigger autoimmune disease?

Sunder Rajan, PhD, CDRH
MRI Safety Testing of Breast Tissue Expanders used in Mastectomy Patients

Ronald Brown, MS, CDRH
Sex differences in biomarkers of kidney injury in patients with metal-on-metal hip implants

Srinidhi Nagaraja, PhD, CDRH
The Effects of Gender Differences in Revision Rates for Spinal Total Disc Replacement Procedures

Zhiwei Zhang, PhD, CDRH
Incremental Values of Sequential Procedures for Diagnosing Breast Cancer

Kenneth Phillips, PhD, CDRH
Effect of Injection Techniques, Materials Chemistry and Physical Properties of Dermal Fillers on Potential for Bacterial Colonization and Infection

James Coburn, MS, CDRH
Mechanical causes of higher hip implant failure rates in women

Do-Hyun Kim, PhD, CDRH
Photo-Thermal Safety in Laser-based Devices for Detection and Treatment of Breast Cancer: Effect of Endogenous Absorbers and Gold Nano-Particles

Robert Wagner, PhD, NCTR
Nanoparticle Effects on Induction of Pro-inflammatory Responses to Candida albicans by Cultured Vaginal Epithelial Cells

Annie Lumen, PhD, NCTR
Population-Based Computational Framework for Assessing Xenobiotic Disposition and Interaction Effects in Pregnant Women-Pilot Study

Beverly Lyn-Cook, PhD, NCTR
Clinical and Biological Significance of Three Identified Targets in Systemic Lupus Erythematosus Patient PBMCs: IL-18, TNFSF13B, and FOXP3

Annie Lumen, PhD, NCTR, (Special Initiative)
Population-Based Computational Framework for Assessing Xenobiotic Disposition and Interaction Effects in Pregnant Women-Pilot Study

Beverly Lyn-Cook, PhD, NCTR, (Special Initiative)
Clinical and Biological Significance of Three Identified Targets in Systemic Lupus Erythematosus Patient PBMCs: IL-18, TNFSF13B, and FOXP3

David Strauss, MD, PhD, CDRH, (Special Funding)
OWH supplemental funds to Dr. Strauss to do the PK analysis of the samples for a study funded by CDER Critical Path.

Return to Top


David Strauss, MD, PhD, CDRH
Gender-Specific Predictors of Heart Failure Hospitalization and Death in Cardiac Resynchronization Therapy

Peter Goering, PhD, CDRH
Safety and Efficacy of Iron Oxide Nanoparticles Used as MRI Contrast Agents for Breast Cancer Imaging

David Strauss, MD, PhD, CDRH
Novel Electrocardiographic Device Algorithms to Assess Cardiac Safety of Investigational Drugs

Tina Morrison, PhD, CDRH
Abdominal Aortic Aneurysms: analysis of patient Characteristics and Anatomy Related to EVAR treatment and outcomes- AAA CARE

Ronald Brown, MS, CDRH
Sex differences in kidney biomarker response following exposure to an orthopedic alloy: Implications for the safety assessment of metal-on-metal hip implants

Andreu Badal-Soler, PhD, CDRH
Development, validation and dissemination of computational modeling tools to estimate radiation dose and image quality of emerging imaging technologies for the diagnosis and staging of breast cancer

Leonardo Angelone, PhD, CDRH
MRI in pregnant patients: A systematic analysis of Radio-frequency heating with multi-transmit technology

Colin Anderson-Smits, MPH, CDRH
A Comparitive Analysis of Adverse Events Between Conventional Tube Ligation and Transcervical Occlusive Devices of the Fallopian Tube for Female Sterilization: A Cohort Study

Meagan Myers, PhD, NCTR
Quantitative oncomutation profile of triple negative breast cancer

Qiang Shi, PhD, NCTR
Identifying drugs that cause women-biased hepatotoxicity by reviewing FDA drug approcal packages/labels and FDA maintained databases and conducting comparitive studies in primary hepatocytes of rats.

Serguei Liachenko, PhD, NCTR
Gender differences in neuronal reward circuit activation by nicotine and tobacco smoke using magnetic resonance spectroscopy

Mikhail Ovanesov, PhD, CBER
Improving safety of blood products administered during pregnancy

Zhiping Ye, PhD/ Xie Hang, PhD, CBER
Development of a mouse model to mimic the response of female and pregnant human subjects to avian influenza infections and to evaluate the protective efficacy of pandemic H5N1 vaccines against highly pathogenic avian influenza

Wen Jin Wu, MD, PhD, CDER
Investigate the mechanisms of trastuzumab-induced cardiotoxicity and cardiotoxicity and cardio protective role of antioxidants in trastuzumab-mediated cardiac dysfunction

Chongwoo Yu, PhD, CDER
Investigation of Drug-Drug Interactions with Hormonal Contraceptives

Jagan Mohan Parepally, PhD, CDER
Gender effect on PK/PD of hypnotic drug: Driving impairment and dosing recommendations

Zhongjun Luo, MD, PhD, CDER
Exploring Potential Safety Issues of PPIs on Osteoporosis in Elderly Women Using the PPI Legacy Database

Sri Rama Krishnaiah Yellela, PhD, CDER
Quantification of drug retained in the skin after removal of estradiol transdermal drug delivery systems used in hormone replacement therapy

Srikanth Nallani, Ph.D, CDER
Applications of Clinical Pharmacology Principles in Pharcotherapy of Diseases in Pregnancy

Lanyan Fang, PhD, CDER
Sex Disparities in Autoimmune Treatment Response

Jack Ragheb, PhD, CDER
A Mechanistic Study of the Capacity of Silicone to Present (Self) Antigens to the Immune System

Return to Top


Pei Zhang, MD, CBER
Prophylaxis of HBV infection with HBIGIV in a pregnant animal model

Deborah Taylor, CBER
The Role of Estrogen in Controlling Hepatitis C Virus Replication

Peiling Yang, PhD, CDER
An investigation of sexual dysfunction in depressive trials

Chongwoo Yu, PhD, CDER
Effects of body mass index (BMI)/body weight (BW) on effectiveness of hormonal contraceptive products for women

Juhong Liu, PhD, CDER
Nuclear Uptake of Transcription Co-Activator JTV1 Induces p53-Meadiated Apoptosis of Ovarian Cancer (OC) Cells – Implications for the Development of New Ovarian Cancer Biomarkers and Therapeutic Targets

Rao, Ashutosh, CDER
Addressing the unmet medical needs for cardioproctection in women receiving chemotherapy

Ta-Chen Wu, PhD, CDER
Pharmacokinetics (PK) and biomarkers of the medications used to treat multiple sclerosis (MS) – any gender difference?

Cara Krulewitch, CNM, PhD, CDRH
Evaluation of safety and effectiveness of mesh implantation in surgical interventions for the treatment of pelvic floor disorders, Phase III

Robert Jennings, PhD, CDRH
Evaluating radiation risks and benefits of breast CT for diagnosing breast cancer

Nicholas Petrick, PhD, CDRH
Reproducibility in the quantitative assessment of multiple tissue-based biomarkers for breast cancer using light and digital microscopy

Dinesh Patwardhan, PhD, CDRH
Sex-based differences in the molecular mechanisms of polymer degradation in drug eluting stents (DES)

Terry Woods, CDRH
Preclinical Test Methods for Percutaneously Implanted Heart Valves: Effect of Non-Circular Valve Configuration After Implantation On Valve Leaflet Dynamics

Rajan Sunder, PhD, CDRH
MRI and Ultrasound imaging of silicone filled breast implants

Ching-Wei Chang, PhD, NCTR
Integrated analysis of single nucleotide polymorphism and copy number variation in genome association of breast cancer

Beverly Lyn-Cook, PhD, NCTR
Sex and ethnic differences in expression of Toll-like receptors (TLR-3, TLR-7, and TLR-9) in systemic lupus erythematous (SLE): new targets for emerging therapeutics

Igor Pogribny, PhD, NCTR
Development of a targeted microRNA-based epigenetic therapeutic approach for breast cancer treatment

James Fuscoe, PhD, NCTR
Genetic and epigenetic mechanisms for sex differences in the kidney of a rat model system: developing safety biomarkers for FDA regulated products

Sean Linder, PhD, ORA
Detection of Nanoscale Materials in Products Targeted to Women: Feminine Hygiene Products and Dietary Supplements

Rallabhandi, Prasad, PhD, CFSAN
Studies of gluten-mediated cell signaling and immune modulation in Caco-2 intestinal epithelial cells: impact on women’s health and celiac disease

Shashi Amur, Special funding/CDER
Lupus Workshop

Katie O'Callaghan, Special funding/CDRH
Prospective assessment of clinical and health status outcomes for female patients undergoing Percutaneous Coronary Intervention (PCI) procedures via femoral and radial access

David Strauss, MD, Special funding/CDRH
Sex-Specific Left Bundle Branch Block Criteria and ECG Scar Quantification to Predict Benefit from Cardiac Resynchronization Therapy (CRT)

Jingyee Kou, PhD, Special funding/CBER
Continuation of a pilot study on performing sex analysis on a vaccine database

Return to Top


Dorothy Scott, M.D. (CBER)
Treatment of progressive vaccinia in a pregnant immunocompromised mouse model

Cara Krulewitch, PhD (CBER)
Evaluation of Safety and Effectiveness of Mesh Implantation in Surgical Interventions for the Treatment of Pelvic Floor Disorders, PHASE II and PHASE III

Ellen Pinnow, PhD (CBER)
Atrial Fibrillation Ablation Registry Study (SAFARI)

Jingyee Kou, PhD (CBER)
A pilot study on on performing sex analysis on a vaccine database

Antonio Paredes, PhD (CDER)
Assessment of Risk Factors Associated with Exposure to Proton Pump inhibitors and Fracture and CV outcomes in post-menopausal osteoporosis woman

Srikanth Nallani, PhD (CDER)
Applications of clinical pharmacology principles in pharmacotherapy of diseases in pregnancy

Christine Garnett, Pharm D (CDER)
Sex and age related differences in baseline QT, QT prolongation, and TdP risk

Guoxing (Greg) Soon, Ph.D (CDER)
Women in HIV trials: a comprehensive review and meta-analysis for safety

Lei Zhang, PhD (CDER)
Evaluation of gender-related clinical pharmacology information in the labelings on adverse events and outcomes

Paul Schuette, PhD (CDER)
An analysis of safety signal detection methods for pregnancy exposure registries

Aldo Badano, PhD (CDRH)
Development of standard color management methods for assessment of immunohistochemical HER2 expression in breast cancer using digital microscopy

Daniel Canos, PhD (CDRH)
The swan-ganz balloon flotation pulmonary artery catheter: possible racial and sex discrepancies

Hesha Duggirala, PhD (CDRH)
Assessment of outcomes and bleeding complications following implantation of drug eluting stents (DES) and dual anti-platelet therapy (DAPT)

Kish Chakrabarti, PhD (CDRH)
Dose and image quality optimizations in various full-field digital mammography systems

Subok Park, PhD (CDRH)
Safety and efficacy of biomarkers using gene expression data for breast cancer patient treatment and care

Dale Tavris, PhD (CDRH)
Risk of Adverse Events following Cardiac Catheterization by Hemostasis Device Use – Phase III

Jon Wilkes, PhD (NCTR)
Quantum mechanical and NMR spectral approaches for the rapid prediction of estrogen activity or new drugs and environmental documents

Doug Wagner, PhD (NCTR)
Effects of phytoestrogens on gene expression responses of vaginal epithelial cells after contact with candida albicans

Return to Top


Indira Hewlett, Ph.D. (CBER)
In vitro studies to assess impact of gender and co-infection with Herpes Simplex virus type 2 on the replication and transmissibility of major emerging HIV-1 variants

Deborah Taylor, Ph.D. (CBER)
The role of estrogen in enhancing innate immunity during viral infection

Luis Valerio, Ph.D. (CDER)
Computational human health effects study to assess the safety of botanical extracts widely used by women in the United States for treatment of menopausal symptoms

Karen Feibus, M.D. (CDER)
Ethics roundtable: the ethics of studying drugs and biologics in pregnant women

Srinidhi Nagaraja, Ph.D. (CDRH)
Do vertebroplasty procedures increase the risk of adjacent level vertebral fractures in osteoporotic women

Malvina Eydelman, M.D. (CDRH)
Quality of life and significant symptoms after LASIK

Katie O’Callaghan, MS. (CDRH)
Analysis of sex-differences in cardiac resynchronization therapy devices: inclusion, adverse events, and outcomes

Dinesh V. Patwardhan, Ph.D. (CDRH)
Sex-based differences in the safety of drug-eluting stents containing bioresorbable materials

Aldo Badano, Ph.D. (CDRH)
Development of a tissue-mimicking physical phantom and quantitative, assessment tools for standardizations, optimization, and NSF risk reduction in dynamic contrast-enhanced MRI of the breast

Iacovos S. Kyprianou, Ph.D. (CDRH)
Women’s radiation dose and excess cancer risk associated with x-ray computed tomography scans: quantification and risk-mitigation strategies

Mark Hart, Ph.D. (NCTR)
Application of co-culture and simulated vaginal models to elucidate the inhibitory properties of naturally occurring and bioengineered strains of lactobacillus toward toxic shock syndrome toxin-1 producing strains of staphylococcus aureus

Weida Tong, Ph.D. (NCTR)
Development of an FDA resource for sex difference-related pharmacogenomics data review-Phase II

Beverly Lyn-Cook, Ph.D. (NCTR)
Women’s health initiative seminar series and workshop at NCTR

Beverly Lyn-Cook, Ph.D. & Athena Davenport, Ph.D. (NCTR)
Inactivation of UDP-Glucuronosyltransferases (UGTs) in human breast and endometrial tissues: accessing cancer risk, tamoxifen safety and toxicity

Cecilia Aguila D.V.M. (CVM)
Genome wide methylation arrays for detecting markers of increased susceptibility to mammary cancer caused by in utero exposures to endocrine disruptors

Return to Top


Mustafa Akkoyunlu M.D., Ph.D. (CBER)
The Role of Vaccine Adjuvant Mediated TACI Up regulation in SLE

Andrew Dayton, Ph.D. (CBER)
Effects of B-Estradiol on the Safety of Anti-HIV Drugs

Christine Garnett, Ph.D., Philip Dinh, Ph.D. (CDER)
Gender-Related Differences in QT Effects and Torsade de Pointes Potential of Drugs

Christy John, Ph.D. (CDER)
Qualifying Imaging Biomarkers to Monitor Neoadjuvant Chemotherapy in Breast Cancer Patients to Identify Responders Using Positron Emission Tomography (PET)

Sandra Kweder, M.D. (CDER)
The Asthma and Allergy Medications in Pregnancy Surveillance System (AAMPSS) Demonstration Project

Nakissa Sadrieh, Ph.D. (CDER)
Evaluating the Effects of Over-the-Counter Skin Products, such as Sunscreen, on the Absorption of Dermally Applied Estradiol, in an In- Vitro and an In-Vivo Model

Ana Szarfman, Ph.D. (CDER)
Detection and Confirmation of Gender Related Safety Signals Using the Electronic Healthcare Data from the Department of Defense

Lei Zhang Ph.D. (CDER)
Safer use of Narcotics in Pregnant and Lactating Women

Kish Chakrabarti, Ph.D. (CDRH)
Dose and Image Quality Optimization in Full Field Digital Mammography

Cara Krulewitch, CNM, Ph.D. (CDRH)
The Safety and Effectiveness of Surgical Mesh Implant Use in Uro-Gynecologic Surgery for Soft Tissue Augmentation

Kathryn M. O’Callaghan, B.S. (CDRH)
Workshop: Guidance for the Study and Analysis of Sex Differences in the Clinical Evaluation of Cardiovascular Medical Devices

Subok Park, Ph.D. (CDRH)
Patient Safety and Imaging Performance of Three-Dimensional (3D) X-Rays Systems for Detection of Breast Cancer

Cunlin Wang, M.D., Ph.D. (CDRH)
Gender Differential in National Estimates for Medical Device-Associated Adverse Events (MDAEs) from Emergency Departments

Thomas Flynn, Ph.D. (CFSAN)
Evaluation of Inflammation and Sex Hormones as Biological Factors that May Contribute to Gender Differences in Susceptibility to Chemical-Induced Liver Injury – Studies Using Human Liver Cells in Culture

Huizhong Chen, Ph.D. (NCTR)
Risk Assessment of Human Skin Microflora Metabolism of Synthetic Azo Colorants used in Women’s Cosmetics

Beverly Lyn-Cook, Ph.D. (NCTR)
Genotyping of Transporter Genes Associated with Gender Differences and Promoter Methylation Profile of UGT1A1 in Human Liver: A Mean of Assessing Safety and Toxicity of Chemotherapeutic Drugs

Doug Wagner, Ph.D. (NCTR)
Gene Expression Responses of Estrogen-Primed Vaginal Epithelial Cells After Contact With Candida albicans and Probiotic Lactobacilli

Steven Tucker, Ph.D, (OC)
Effects of Proposed Revisions to the Regulations Implementing the Mammography Quality Standards Act

Return to Top


Indira Hewlett, Ph.D. (CBER)
Evaluation of Gender Differences in Detection, Replication and Transmissibility of Emerging HIV-1 Variants

Deborah Taylor, Ph.D. (CBER)
The Role of Estrogen in Enhancing Innate Immunity During Viral Infection

Shashi Amur, Ph.D. (CDER)
Gender, Ethnicity and Pharmacogenomics in Systemic Lupus Erythematosus (SLE)

Audrey Gassman, M.D. (CDER)
Workshop: Drugs in Pregnancy

Yongsheng Yang, Ph.D. (CDER)
Identification of Sex Differences in Adverse Outcomes for New Molecular Entities (NMEs) Approved from 2000-2002

Soma Kalb, Ph.D. (CDRH)
Factors Accelerating the Progression of Heart Failure (HF) in Women: Implications for Drug Interactions with Medical Devices

Dinesh Patwardhan, Ph.D. (CDRH)
The Impact of Sex-Based Differences in Atherosclerotic Plaque on the Response to Drug Eluting Stent Implantation

Art Sedrakyan, MD, Ph.D. (CDRH/AHRQ)
Real-World Outcomes of Drug-Eluting Stents

Elizabeth Calvey Ph.D., Marjorie Davidson, Ph.D. (CFSAN)
Understanding Consumer Behavior Associated with Changing Messages on Listeria monocytogenes and Food Safety

Neera Gopee, Ph.D. (NCTR)
Sex differences in Systemic Lupus Erythematosus (SLE): Effects of a single nucleotide polymorphism (SNP) in the prolactin (PRL) gene on individual response to prasterone therapy

Baitang Ning, Ph.D. (NCTR)
Mechanisms of Gender Differences in Aspirin Effects: Metabolizing Enzymes and Therapeutic Targets

Weida Tong, Ph.D. (NCTR)
Development of a FDA Resource for Improved Efficiency of Sex Difference Related Pharmacogenomic Data Analysis and review

Lesley Kerr, Ph.D. (ORA)
Development of a Rapid Version of the Tampon Test Method Based on 21CFR801.430

Phyllis Wilson, Ph.D. (ORA)
Development and Validation of an HPLC Method for the Simultaneous Determination of Estradiol, Estriol, Estrone and Progesterone in Pharmaceutical Preparations

Extramural studies:

Bram Zukerman PhD, Norman Stockbridge, PhD, Duke Clinical Research Institute
Drug Eluting Stent (DES)/Thrombosis

Return to Top


Hana Golding, Ph.D., Surender Khurana, Ph.D. (CBER)
HIV SELECTEST A Novel Assay for Diagnosis of HIV Infections in the Presence of Antibodies Induced by Candidate HIV Vaccines: Evaluation of Gender Bias in Sensitivity and Specificity

Shashi Amur, Ph.D. (CDER)
Gender Differences and Impact of Pharmacogenomics in Rheumatoid Arthritis

Angela Men, Ph.D., Shashi Amur, Ph.D. (CDER)
Impact of Gender Analysis and Pharmacogenomics on Clinical Efficacy, Safety, and Pharmacokinetics of Drugs Used for the Treatment of Alzheimer’s Disease.

Jogarao Gobbura, PhD. (CDER)
Quantitative Tumor Size - Survival Relationship in Oncology Clinical Trials

Ohidul Siddiqui, Ph.D. (CDER)
Statistical Analysis of Gender Specific Data from New Drug Application (NDA) Submissions

Guoxing (Greg) Soon, Ph.D. (CDER)
Women in HIV Trials: A Comprehensive Review and Meta-Analysis

Mary Willy, Ph.D. (CDER)
Drug Use in Pregnancy

Anne Trontell, MD, MPH., (CDER/AHRQ)
Research on the Effects of Drug Exposure in Pregnancy

Yongsheng Yang, Ph.D. (CDER)
Participation of Women in Clinical Trials and Gender Analysis of Data in Original NDAs Approved 2000-2002

Jove Graham, Ph.D. (CDRH)
Evaluating the Effectiveness of Vertebroplasty for Improving the Mechanical Properties of the Spine in Patients with Osteoporosis.

Kathryn O’Callaghan B.S. (CDRH)
Evaluation of Availability and Quality of Information Available on Females Included in Mechanical Device Implant Trials.

Varsha Desai, Ph.D. (NCTR)
Molecular Mechanisms Underlying Gender-associated Differences in the Adverse Reactions to the Anti-retroviral Agent, Zidovudine (AZT) Role of Mitochondrial Toxicity

Christopher Elkins, Ph.D., Mark Hart, Ph.D. (NCTR)
Protective Effect of Vaginal Lactobacillus Species Against Staphylococcus Aureus-mediated Toxic Shock Syndrome

Beverly Lyn-Cook, Ph.D. (NCTR)
Sex Differences in Chemotherapeutic Toxicity: Profiling of Transporter Genes in Human Liver

Extramural studies:

Kara Morgan, Ph.D. (OC)
Phase I - II Mental Modeling Research of how best to communicate to health care providers about the risks and benefits of prescription drug use for pregnant or Lactating Women with Chronic Conditions

Christopher Cabell, M.D., MHS, Duke Clinical Research Institute (DCRI)
ECG Warehouse - Duke Clinical Research Institute and Duke University

Justin Mortara, Mortara Instrument Inc.
ECG Warehouse - Mortara Instruments Inc.

Ray Woosley, MD, Ph.D., The Critical Path Institute
The Molecular Assays and Targeted Therapies (MATT) Consortium

Gloria Sarto, MD., University of Wisconsin
Pharmacokinetics and Pharmacodynamics of Selected Antibiotics during Pregnancy

Return to Top


Hyojong Kwon, Ph.D., Robert Lionberger, Ph.D. (CDER)
Sex Difference Dependent Drug-drug Interactions of Anti-HIV Therapeutics

Iacovos Kyprianou, Ph.D., Kyle Myers, Ph.D. (CDRH)
Implications of Gender-based Differences in Cardiovascular Disease on Imaging for Treatment and Diagnosis

Azadeh Shoaibi, M.S., MPH, Dale Tavris M.D. MPH (CDRH)
Assessment of the Accuracy of the Troponin Assay and the Diagnosis of Myocardial Infarction by Gender/ How Gender Influences Treatment

James Fuscoe, Ph.D. (NCTR)
Systems Biology Approach to Evaluate Sex Differences in the Heart of a Rat Model

Extramural studies:

Karen Freund, MD, Boston University
Use and Outcomes of Coronary Stents in Women: Use of a National Medicare Database

Erin G. Schuetz, Ph.D.
CYP2B6 Genotype-Phenotype and the Influence of Sex and Ethnicity

Return to Top


Felice D’Agnillo, Ph.D. (CBER)
Gender Based Differences in the Vascular Response to Anthrax Toxin: Investigation of the Role of Hormones in an In Vitro Human Endothelial Cell Culture System

Andrew Dayton, Ph.D. (CBER)
Gender Dimorphism in HIV Infection in Primary Macrophages and T-Lymphocytes Kinetics of HIV Replication and Efficacy of Anti-Retroviral Agents

Ellen Tabak, Ph.D, Leslie Wheelock, Ph.D. (CDER)
Gender Differences in the Willingness to Read and Follow Patient Information

Jove Graham, Ph.D. (CDRH)
Development of Guidelines for Evaluating the Appropriateness of Vertebroplasty Surgery for Patients with Osteoporosis

Maria Lorenzo, DVM, Mona S. Calvo, Ph.D. (CFSAN)
Do Phytoestrogens Modify the Allergic Response to Food Allergens in the Newly Validated, Highly Sensitive, In-Bred Asthmatic Rat Model?

Robert Sprando, Ph.D. (CFSAN)
Developmental Toxicity of Androstenedione in Rats

Extramural studies:

Mary Hebert, Pharm D, University of Washington
Pharmacokinetics and Pharmacodynamics (PK/PD) of Atenolol in Lactating Women

Stephen Hall, PhD, Indiana University
Drug Metabolism in Women

Michelle Dew, MD, University of Arizona
Transmission Attenuation Correction for Female Patients Undergoing Myocardial Perfusion Imaging: Correction for Confounding Breast Tissue Artifact

Thierry LeJemtel, MD, Tulane University
Pilot Study: Combined Beta1 Arg 389 and Alpha 2c Del 322-325 Adrenergic Receptor Polymorphisms and Heart Failure with Preserved Left Ventricular Ejection Fraction in African American Women

Return to Top


Jogarao Gobburu, Ph.D. (CDER)
Are Women at Higher Risk from Proarrhythmic Drugs?

Eugene Herman, Ph.D. (CDER)
Discovery and Evaluation of Interspecies Biomarkers to Monitor the Early Onset and the Progression of Cardiovascular Toxicity Associated with Tiazolidinedione Compounds Used in the Treatment of Type 2 Diabetes

John. Koerner, Ph.D.(CDER)
Electrophysiological Characterization of Several Torsadogenic Drugs in Isolated Rabbit Hearts

Melvin Stratmeyer, Ph.D. (CDRH)
Cardiovascular Effects of Ultrasound Contrast Agents in Intact and Ovariectomized Female Animals

Extramural studies:

William Cooper, MD MPH, Vanderbilt University
Assessment of Maternal Effects & Infant Outcomes Using Large Automated Healthcare Data Systems in Women Exposed to Prescription Medications During Pregnancy

Caroline Apovian, MD, Boston University
Self-Monitoring of Blood Glucose with Finger-Tip versus AST: Effect on Long term Glycemic Control

Marlene Freeman, MD, Arizona Health Science Center
Maternal Antidepressent Drug Research and Evaluation (Madre): Pharmacokinetics and Pharmacodynamics of Sertraline in Pregnant and Postpartum

Return to Top


Daniela Verthelyi, Ph.D. (CBER)
Effect of Sex Hormones on the Immune Response to CpG ODN

Mei Ling Chen, Ph.D. (CDER)
Gender Effect on the Assessment of Bioavailability and Bioequivalence Gender Differences in Intestinal Levels of CYP3A4, CYP 3A5, P-gP and MRP

Dale Tavris, M.D. MPH (CDRH)
Incidence and Attributable Risk of Serious Adverse Events and Death Associated with the Use of Homeostasis Devices by Gender

Robert Sprando, Ph.D. (CFSAN)
Characterization of the Effect of Pre-pubertal and Pubertal Exposure of Androstenedione on Female Reproductive Health

Angela Harris, Ph.D. (NCTR)
Development and Characterization of Conditionally Immortalized Human Primary Hepatocyte Cell Lines From Female And Male Donors -- Phase I

Extramural studies:

Mary Hebert, Pharm D, University of Washington
Pharmacokinetics and Pharmacodynamics (PK/PD) of Atenolol in Pregnancy

Raymond Galinsky, Indiana School of Medicine
Ciprofloxacin and Doxycycline in lactating women and in the elderly

Return to Top


Hana Golding, Ph.D., Marina Zaitseva, Ph.D. (CBER)
Thymic Regeneration and Immune Function Reconstitution in Babies Born to HIV-infected Mothers

Eugene A. Herman, Ph.D., Frank Sistare Ph.D. (CDER)
Discovery and Evaluation of Interspecies Biomarkers to Identify and Characterize the Cardiotoxic Effects of Herceptin, a Novel Antibody Used in the Treatment of Breast Cancer

Shew-Mei Huang, Ph.D., Steven Hall Ph.D. (CDER)
The Effects of Echinacea on Cytochrome P450 Enzymes and Oral Contraceptives

Shinya Ito, M.D., Gerald Fetterly, Ph.D. (CDER)
Drug Update in Human Mammary Gland Epithelia

Patrick J. McNamara, Ph.D., Gerald Fetterly, Ph.D. (CDER)
Development of a General Approach for the Investigation of Drug Transfer in Breast Milk: In Vitro Assessment of Drug Distribution into Breast Milk

Rosalie Elespuru, Ph.D., Roselie Bright, Sc.D. (CDRH)
Developing a Diagnostic Gene Expression Profile for Latex Sensitivity Using Microarrays

Sharon Miller M.S., Janusz Beer, Ph.D. (CDRH)
Optimization of UV Exposure Patterns Maximizing Perceived Benefits While Minimizing Photocarcinogenic/photo-aging Effects

Extramural studies:

James Fischer, Pharm D, University of Illinios
Labetalol and Hypertension in Pregnancy: Pharmacokinetics and Pharmacodynamics

Mary Hebert, Pharm D, University of Washington
The PK of Amoxicillin during Pregnancy and Postpartum

Return to Top


Debra Birnkrant, M.D., Ajaz Hussain, Ph.D. (CDER)
Vaginal Volume: Optimizing Vaginal Deployment of Topical Microbicides

Ann Farrell, M.D., Lilia Talarico, M.D. (CDER)
Women's Participation in Clinical Drug Trials for Unstable Angina and Myocardial Infarction

Ronald Honchel, Ph.D., Frank Sistare, Ph.D. (CDER)
Evaluation of the Tg.AC Transgenic Mouse as a Model for Predicting the Photocarcinogenicity of Pharmaceuticals and Cosmeceuticals

Ronald Kaczmarek, M.D. (CDRH)
Surveillance of Sex-specific Utilization, Morbidity, and Mortality Associated with Transmyocardial Revascularization

Richard Kotz, Ph.D. (CDRH)
A Study to Evaluate the Consistency of T-scores Among Ultrasound Bone Measurement Devices and the Usefulness of these Devices for Monitoring Bone Status

Jeffrey Yourick, Ph.D. (CFSAN)
Teratogenic Potential of Cosmetic Products Containing Retinol (Vitamin A) and Retinyl Palmitate-Phase I

Jurgen von Bredow, Ph.D. (CVM)
Use of a Unique Animal Model to Study Placental Milk Transfer of Ciprofloxicin from the Dam to the Offspring During the Perinatal Period

Anane Aidoo, Ph.D. (NCTR)
Evaluation of the Effects of Daidzein And Genistein on The Genotoxic and Carcinogenic Activity of the Model Mammary Carcinogen 7,12-Dimethylbenz(A) Anthracene (DBMA) in Ovariectomized Transgenic Big Blue Rats

Vasily Dobrolovsky, Ph.D. (NCTR)
Evaluation of the Tk Knockout Mouse as a Model of Systemic Lupus Erythematosus

Jeffery Archer, M.S. (ORA)
Analysis of Dioxins/Furnas (17 congeners) Levels in Tampons

Extramural studies:

Gail Mahady, PhD, University of Illinois at Chicago
Pattern of botanical dietary supplement usage in menopausal women

Francine Welty, MD PhD, Beth Israel Deaconess Medical Center and Harvard U
Effects of dietary soy and calcium supplementation on lipid levels, brachial artery function, biochemcial markers of bone turnover, inflammatory markers of atherosclerosis and menopuasal symptioms in postmenopausal women

Stephen Hall, PhD, Indiana University
The effects of St Johns Wort on the efficacy of oral contraception

Sara Warber, MD, University of Michigan
Review of herbal weight loss product experiences and adverse events.

Mara Vitolins, DrPH, Wake Forest University
Use and interaction of dietary supplements in the SEA Trial.

Gail Anderson, PhD, University of Washington
Phytoestrogens: Drug interaction potential in women

Return to Top


Vance Berger, Ph.D. (CBER)
Improving the Evaluation of Ovarian Cancer Treatment

Carolyn Deal, Ph.D. (CBER)
Hormone Effects on Pathogenesis & Host Cell Interactions of N. Gonnorrhea

Chandra Sahajwalla, Ph.D. (CDER)
Evaluation of In-vitro Mechanistic Basis for Gender Dependant Differences in Pharmacokinetics

Mary Willy, Ph.D. (CDER)
Post-marketing Drug Risk Assessment Using the ARAMIS Database in RA Patients

Rosalie Bright, Sc.D. (CDRH)
Active Postmarketing Surveillance Methods: A Hospital Pilot

Robert Navario, Ph.D, S.L.Brown, M.D. (CDRH)
Assessment of Consumer Understanding of Barrier Contraception and Tampon Labeling: Focus Group Studies

Robert Bronaugh, Ph.D. (CFSAN)
Potential Exposure of Women to Estrogens, Phytoestrogens and Xenoestrogens through Cosmetic Products

Dean Roberts, Ph.D. (NCTR)
Antigenic Biomarkers of Estrogen Catechol Metabolism for Post-Market Surveillance of Oral Contraceptives and HRT's

Return to Top


Frederick Miller, M.D., Ph.D. (CBER)
Silicone Gel-filled Breast Implant Capsules: A Molecular Histologic and Immunophenotypic Study

Emily Shachter, Ph.D. (CBER)
Improve the Efficacy of Chemotherapeutic Drugs for the Treatment of Breast Cancer

Kathryn Aiken, Ph.D. (CDER)
Pregnancy Labeling Taskforce Focus Group testing (co-funded by NIH ORWH)

Shiew Mei Huang, Ph.D., Robert Branch, Ph.D. (CDER)
Gender Differences in P450 Activities and their Implications (co-funded by NIH ORWH)

Thomas Layloff, Ph.D. (CDER)
Chemical Characteristics of Conjugated Estrogens

Ralph Lillie, RPh (CDER)
Adverse Events Reporting System (AERS): Risk assessment, Compliance & Management

Carolyn McCloskey, M.D., MPH (CDER)
Teratogen Surveillance

Ana Szarfman, M.D., Ph.D. (CDER)
Data Mining Techniques for Identifying Potential Serious Drug Interactions in Women

Ana Szarfman, M.D., Ph.D., Raymond L. Woosley, M.D., Ph.D. (CDER)
Variations in the Drug-induced QT Interval Prolongation During the Menstrual Cycle (Co-funded by NIH ORWH)

Kenneth T. Durham, Ph.D. (CFSAN)
CFSAN's Internet Initiative: Infra-structure Support

Nancy Slifman, M.D., MPH (CFSAN)
Contaminants in Dietary Supplements Frequently Used in Women

Patricia Dubill, Ph.D. (CDRH)
Abrasion Testing of Breast Implants

James Karanian, Ph.D. (CDRH)
Ovarian Steroids and Cardiovascular Disease the Role of Gender in the Effectiveness of Interventional Medical Devices

Harvey Rudolph, Ph.D. (CDRH)
Accelerated Aging Studies of Condoms/condom Materials

Harvey Rudolph, Ph.D. (CDRH)
Flow Studies and the Use of a Waveguide in Cardiovascular Devices

Keith Wear, Ph.D. (CDRH)
Development and Validation of Ultrasonic Backscatter Measurement for Bone Density Assessment

Patricia Thompson, Ph.D. (NCTR)
In-Vivo Modeling Of Steroid-Mediated Gender Effects in Drug Metabolism (Phase I and II)

Lesley Kerr, Ph.D. (ORA)
Development and Validation of a Universal Water Leak Test Method for Barrier Contraceptives

Return to Top


Margaret Bash, M.D., MPH (CBER)
Antigenic Characteristics and Immunogenicity of Synthetic Peptide Vaccines for the Pathogenic Neisseria: Neisseria meningitides and Neisseria gonorrhea

Hana Golding, Ph.D. (CBER)
Sexual transmission of HIV-1 in Women and Mother to Infant Transmission: The Importance of HIV-1 Co-receptor Expression on Cerviovaginal Cells and on Cord Blood Cell Subsets

John Strong, Ph.D. (CDER)
Contribution of Estrogen Components to the Efficacy of Conjugated Estrogens - Preliminary Analytical Chemistry

Ana Szarfman, M.D., Ph.D. (CDER)
Visualization Tools for Studying Gender Differences

S. Lori Brown M.D. (IOM/CDRH)
Institute of Medicine Study: A Study of Safety of Silicone Breast Implants

S. Lori Brown, M.D. (CDRH)
Protocol for a Study of Breast implant rupture

Rosalie Bright, Sc.D. (CDRH)
Mammography Breast Cancer Screening Rates Among Disadvantaged Women within a Pre-Paid Health Care System

Robert Jennings, Ph.D. (CDRH)
Optimization of mammography

Steven Lascher, DVM, MPH (CDRH)
A Comparison of Gender Specific Utilization of Implantable Cardioverter Defibrillator Therapy and Post-implantation Survivability

Danica Marinac-Dabic, M.D. (CDRH)
Epidemiology of Medical Devices in Women (conference)

Shirley R. Blakely, Ph.D. (CFSAN)
Obesity: Its Effect on Antioxidant and Estrogen Metabolism

Mona S. Calvo, Ph.D. (CFSAN)
Vitamin K Status of Non-Hispanic Black and White Girls and Young Adult Women: Direct Measure of Serum Phylloquinone Levels and Measurement of a New Functional Endpoint in Serum Samples from NHANES III

Christine B. Ambrosone, Ph.D. (NCTR)
Breast Cancer in African-American Women: Metabolic Modification of Dietary and Hormonal Risk Factors

S. Jill James, Ph.D. (NCTR)
Molecular and Metabolic Determinants of Maternal Risk and Progression of Down's Syndrome Potential for Nutritional Intervention

William H. Tolleson, Ph.D. (NCTR)
Development Of In Vitro Human Cell Culture Systems to Screen Compounds Suspected To Have Estrogenic or Anti-Estrogen Activity

Return to Top


Dennis Klinman, M.D., Ph.D. (CBER)
A Novel Approach to the Treatment of Lupus Nephritis

Penelope Robbins, Ph.D. (CBER)
Human Cytotoxic T Lymphocyte Recognition of Papilloma Virus

Emily B. Shachter, Ph.D. (CBER)
Administration of Thrombolytic Therapy to Women with Acute Myocardial Infarction: Is It Too Late?

Giovanna Tosato, M.D. (CBER)
IP-10: A Potential New Therapeutic for Breast Cancer

Donna A. Volpe, Ph.D. (CDER)
In Vitro Prediction of Time to Neutropenic Nadir: Anti-neoplastic Alkylating Agents as Prototype Drugs

Marwood N. Ediger, Ph.D. (CDRH)
Development of a Safe, Economical Assay for Silicone Containment in Blood and Tissue

Melvyn Greberman, M.D., MPH (CDRH)
The Transfer of Defense, Intelligence and Space Technologies for the Early Detection and Control of Cancers in Women (conference)

Matthew R. Myers, Ph.D. (CDRH)
A Computer Model for Simulating Virus Transport through Barriers

Kenneth T. Durham, Ph.D. (CFSAN)
CFSAN’s Women's Health Internet Initiative - Phase II

Thomas J. Sobotka, Ph.D. (CFSAN)
Screening for Nervous System Dysfunction in Offspring of Dams Exposed to Natural Food Contaminates During Pregnancy

Ruth A. Welch, Ph.D. (CFSAN)
Women’s Health Information Line

Frederick A. Beland, Ph.D. (NCTR)
DNA Adducts of Tamoxifen

Darnell Carlton Jackson, Ph.D. (NCTR)
Development of an Estrogen Knowledge Base for Research and Regulation

Daniel M. Sheehan, Ph.D. (NCTR)
Experimental Assessment of Environmental Estrogens

Return to Top


David S. Finbloom, M.D. (CBER)
Cytokine Induced Activation of the Jak Kinase/STAT Transcription Factor Pathway in Immune Cells (Monocytes and Lymphocytes) of Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus

Basil Golding, M.D. (CBER)
Induction of Mucosal Immunity to Protect Females from HIV-1

Dennis Klinman, M.D., Ph.D. (CBER)
Hormonal Regulation of Cytokine-producing Cells in Women with Systemic Lupus Erythematosus

Philip R. Krause, M.D. (CBER)
Development of a Method to Evaluate the Effect of Vaccines and Antiviral Therapy on Latent Viral Burden in an Animal Model of Genital Herpes

Carol B. Trapnell, M.D. (CDER)
The Effect of Thalidomide on the Pharmacokinetics of Ethinyl Estradiol and Norethindrone

Edwin J. Matthews, Ph.D. (CDER)
Estimation of Reproductive Toxicity of Pharmaceuticals Using QSAR Software Programs

Bruce V. Stadel, M.D. (CDER)
Hormone Replacement Therapy in Women with a Previous Diagnosis of Endometrial Cancer

Ellen R. Tabak, Ph.D. (CDER)
Gender Differences in Perception of Risks Communicated by Prescription and Over-the-counter Drug Labels, Phase I and II

Brenda Vaughan, M.D. (CDER)
Thalidomide: Are There Gender Disparities in Treatment Outcome and Non-teratogenic Adverse Effects?

Sheila Weiss, Ph.D. (CDER)
Profile of Drug Use in Pregnancy

Danica Marinac-Dabic, M.D. (CDRH)
Gender Differences in Early and Long-term Results of Coronary Angioplasty with Palmaz/Schatz Stent

Kyle Myers, Ph.D. (CDRH)
Non-invasive Assessment of Silicone Migration from Gel-filled Breast Implants

Paula G. Silberberg, M.D. (CDRH)
Contraceptive Efficacy Table for Uniform Contraceptive Labeling-- a Consumer Focus Group Study - Part I and II

Keith A. Wear, Ph.D. (CDRH)
Application of Ultrasonic Tissue Characterization to Diagnosis of Bone Disease

Kenneth T. Durham, Ph.D. (CFSAN)
CFSAN’s Women's Health Internet Initiative - Phase I

Mary L. Tortorello, Ph.D. (CFSAN)
Rapid Method for Detection and Enumeration of Listeria Monocytogenes in Foods

Ruth Welch Ph.D., Carole Schiffman Ph.D. (CFSAN)
Osteoporosis Prevention in Adolescent Girls

John Leighton, Ph.D. (CVM)
A Novel Molecular Approach to Risk Assessment of Hormonally Active Compounds

Peter Rheinstein, M.D., JD (OEA)
Research Involving Human Subject Committee (RIHSC)

Teresa Toigo, RPh, MBA (OEA)
Development and Expansion of a Pilot Tracking System for Monitoring the Barriers to the Enrollment of Women in Clinical Trials

S. Jill James, Ph.D. (NCTR)
Mechanism of Immunotoxicity and Carcinogenicity Associated With Silicone Breast Implants

Randal Streck, Ph.D. (NCTR)
Mechanism of Tamoxifen Development Toxicity and Neoplasia Tamoxifen Effects on the Rat Uterine Insulin Like Growth Factor System

Barbara Ward-Groves, MPH (ORA)
Mammography Quality Standards Act Facilities Workshop

Return to Top


Frederick W. Miller, M.D., Ph.D. (CBER)
Immunogenetic Risk Factors for Silicone-associated Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Michael A. Norcross, M.D. (CBER)
Women and AIDS Transmission

Carol B. Trapnell, M.D. (CDER)
An Open-label, Randomized, Cross-over, Feasibility Study to Quantify the Retention of Vaginally Administered Nonoxynol-9 (N-9) Foam in Premenopausal Women

Lou Cantillina, M.D. (CDER)
Women in Clinical Trials Terfenadine/Oral Contraceptive Study

David Flockhart, M.D., Ph.D. (CDER)
Comparison of the Beta-adrenergic Antagonist Actions of Propranolol in Men and Women

Raymond L. Woosley, M.D., Ph.D. (CDER)
Comparison of the Potassium Channel Blocking Actions of Quinidine in Men and Women

John Langone, Ph.D. (CDRH)
Silicone Gel Alternatives Workshop

Carol Sierka, B.S. (CDRH)
Consumer Brochure on MammographyDevelopment of MQSA Speaker Kits

John E. Bailey, Ph.D. (CFSAN)
Cosmetics Initiatives Alpha Hydroxy Acids (AHAs)

John E. Bailey, Ph.D. (CFSAN)
AHA Literature Search

Sara B. Fein, Ph.D. (CFSAN)
Infant Feeding Practices Study

Dan Sheehan, Ph.D. (NCTR)
Effects of Toremifene and ICI 182,780 on Rat Uterine Growth and Differentiation

Conference on STD Clinical Trials Workshop (NIH and OEA)
April 6-8, 1994

OWH Small Grants Program (OC)
Workshop: FDA-regulated Products and Pregnant Women

Page Last Updated: 03/11/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.